OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +19.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 3.67M | -0.5% | $21.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.86M | — | $10.83M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.68M | +34.4% | $9.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.68M | +34.4% | $9.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.53M | +52.1% | $8.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.53M | +52.1% | $8.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.53M | +52.1% | $8.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.53M | +52.1% | $8.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 979.22K | +1154.4% | $5.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasivo) | 926.16K | -0.9% | $5.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 926.16K | -0.9% | $5.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 365.20K | -8.7% | $2.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 192.94K | -19.7% | $1.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 192.94K | -19.7% | $1.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 157.30K | +435.0% | $917,059 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 72.88K | -27.2% | $424,873 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 26.11K | -17.0% | $153,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 12.45K | -51.4% | $72,554 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 200.00K acciones, $10,000 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.